IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v572y2019i7767d10.1038_s41586-019-1380-3.html
   My bibliography  Save this article

Author Correction: Genomic characterization of metastatic breast cancers

Author

Listed:
  • François Bertucci

    (CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes)

  • Charlotte K. Y. Ng

    (University Hospital Basel
    University of Basel
    University of Bern)

  • Anne Patsouris

    (Inserm, U1232
    Institut de Cancérologie de l’Ouest - René Gauducheau)

  • Nathalie Droin

    (Genomic Core Facility UMS AMMICA Gustave Roussy Cancer Campus
    INSERM, US23
    CNRS, UMS3665)

  • Salvatore Piscuoglio

    (University Hospital Basel
    University of Basel)

  • Nadine Carbuccia

    (CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes)

  • Jean Charles Soria

    (Université Paris Sud
    Gustave Roussy Cancer Campus)

  • Alicia Tran Dien

    (Gustave Roussy Cancer Campus)

  • Yahia Adnani

    (Gustave Roussy Cancer Campus)

  • Maud Kamal

    (Institut Curie)

  • Séverine Garnier

    (CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes)

  • Guillaume Meurice

    (Gustave Roussy Cancer Campus)

  • Marta Jimenez

    (Unicancer)

  • Semih Dogan

    (Inserm, Gustave Roussy Cancer Campus, UMR981)

  • Benjamin Verret

    (Inserm, Gustave Roussy Cancer Campus, UMR981)

  • Max Chaffanet

    (CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes)

  • Thomas Bachelot

    (Centre Léon Bérard)

  • Mario Campone

    (Inserm, U1232
    Institut de Cancérologie de l’Ouest - René Gauducheau)

  • Claudia Lefeuvre

    (Centre Eugène Marquis)

  • Herve Bonnefoi

    (Institut Bergonié)

  • Florence Dalenc

    (Institut Claudius-Regaud, IUCT-oncopôle)

  • Alexandra Jacquet

    (Unicancer)

  • Maria R. Filippo

    (University Hospital Basel)

  • Naveen Babbar

    (Novartis Pharmaceuticals Corporation)

  • Daniel Birnbaum

    (CRCM, Predictive Oncology team, Inserm, Aix-Marseille Univ, CNRS, Institut Paoli-Calmettes)

  • Thomas Filleron

    (Institut Claudius-Regaud, IUCT-oncopôle)

  • Christophe Tourneau

    (Institut Curie
    INSERM U900
    Versailles Saint Quentin en Yvelines University)

  • Fabrice André

    (Université Paris Sud
    Inserm, Gustave Roussy Cancer Campus, UMR981
    Gustave Roussy)

Abstract

An Amendment to this paper has been published and can be accessed via a link at the top of the paper.

Suggested Citation

  • François Bertucci & Charlotte K. Y. Ng & Anne Patsouris & Nathalie Droin & Salvatore Piscuoglio & Nadine Carbuccia & Jean Charles Soria & Alicia Tran Dien & Yahia Adnani & Maud Kamal & Séverine Garnie, 2019. "Author Correction: Genomic characterization of metastatic breast cancers," Nature, Nature, vol. 572(7767), pages 7-7, August.
    • Handle: RePEc:nat:nature:v:572:y:2019:i:7767:d:10.1038_s41586-019-1380-3
    DOI: 10.1038/s41586-019-1380-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-019-1380-3
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-019-1380-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jian Ma & Lei Li & Bohan Ma & Tianjie Liu & Zixi Wang & Qi Ye & Yunhua Peng & Bin Wang & Yule Chen & Shan Xu & Ke Wang & Fabin Dang & Xinyang Wang & Zixuan Zeng & Yanlin Jian & Zhihua Ren & Yizeng Fan, 2024. "MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    2. Aditya Bardia & Sarat Chandarlapaty & Hannah M. Linden & Gary A. Ulaner & Alice Gosselin & Sylvaine Cartot-Cotton & Patrick Cohen & Séverine Doroumian & Gautier Paux & Marina Celanovic & Vasiliki Pele, 2022. "AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    3. Jorge Gómez Tejeda Zañudo & Romualdo Barroso-Sousa & Esha Jain & Qingchun Jin & Tianyu Li & Jorge E. Buendia-Buendia & Alyssa Pereslete & Daniel L. Abravanel & Arlindo R. Ferreira & Eileen Wrabel & Ka, 2024. "Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    4. Yael Aylon & Noa Furth & Giuseppe Mallel & Gilgi Friedlander & Nishanth Belugali Nataraj & Meng Dong & Ori Hassin & Rawan Zoabi & Benjamin Cohen & Vanessa Drendel & Tomer Meir Salame & Saptaparna Mukh, 2022. "Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    5. Jianjie Li & Xiaodong Shu & Jun Xu & Sek Man Su & Un In Chan & Lihua Mo & Jianlin Liu & Xin Zhang & Ragini Adhav & Qiang Chen & Yuqing Wang & Tingting An & Xu Zhang & Xueying Lyu & Xiaoling Li & Josh , 2022. "S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    6. S. Mouron & M. J. Bueno & A. Lluch & L. Manso & I. Calvo & J. Cortes & J. A. Garcia-Saenz & M. Gil-Gil & N. Martinez-Janez & J. V. Apala & E. Caleiras & Pilar Ximénez-Embún & J. Muñoz & L. Gonzalez-Co, 2022. "Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    7. Antonio Rodriguez-Calero & John Gallon & Dilara Akhoundova & Sina Maletti & Alison Ferguson & Joanna Cyrta & Ursula Amstutz & Andrea Garofoli & Viola Paradiso & Scott A. Tomlins & Ekkehard Hewer & Ver, 2022. "Alterations in homologous recombination repair genes in prostate cancer brain metastases," Nature Communications, Nature, vol. 13(1), pages 1-10, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:572:y:2019:i:7767:d:10.1038_s41586-019-1380-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.